title: Hyperammonemia, resolved by chemotherapy.
authors.affiliation: Pneumology Department, ZOL Genk, Schiepse Bos 6, 3600, Genk, Belgium, nikolaas.demaeyer@gmail.com.
authors.forename: N
authors.initials: N
authors.lastname: De Maeyer
authors.forename: W
authors.initials: W
authors.lastname: Meersseman
authors.forename: D
authors.initials: D
authors.lastname: Dierickx
authors.forename: M
authors.initials: M
authors.lastname: Delforge
authors.forename: J
authors.initials: J
authors.lastname: Wauters
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003128:Coma / Q000097:blood / Q000209:etiology*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D010265:Paraproteinemias / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010956:Plasmapheresis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis; D011719:Pyrazines / Q000008:administration & dosage; D012121:Respiration, Artificial
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide